Edward James Johns

Edward James Johns

Auto-generated profile, based on publicly available information

Edward James Johns

University College Cork

Research Focus & Metrics

Academic Career Length

58Years (1969-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2011
Verified
Book Chapter
Closed access
PDF file
EJEdward J. Johns
Edward J. Johns
UKUlla C. Kopp
Ulla C. Kopp
GDGerald F. DiBona
Gerald F. DiBona

1 October 1972 in The Journal of Physiology
Verified
Journal Article
Closed access
PDF file
JCJ. H. Coote
J. H. Coote
EJE. J. Johns
E. J. Johns
VMValerie H. Macleod
Valerie H. Macleod
BSBertha Singer
Bertha Singer

1 November 2011 in Hypertension
Verified
Journal Article
Closed access
FMFergus P. McCarthy
Fergus P. McCarthy
SDSascha Drewlo
Sascha Drewlo
FEFred A. English
Fred A. English
JKJohn Kingdom
John Kingdom
EJEdward J. Johns
Edward J. Johns
SWSarah K Walsh
Sarah K Walsh
Preeclampsia, a major cause of maternal and perinatal mortality and morbidity, is thought to be attributed, in part, to impaired trophoblast invasion. Peroxisome proliferator-activated receptors are ligand-activated transcription factors expressed in trophoblasts, which regulate the expression of a number of genes involved in cell differentiation and proliferation. We investigated the effect of the administration of a peroxisome proliferator-activated receptor-γ antagonist during uncomplicated pregnancy in rats. Using an intraperitoneal miniosmotic pump, healthy pregnant rats were administered either vehicle or the peroxisome proliferator-activated receptor-γ–specific antagonist, T0070907 (1 mg/kg per day from gestational days 11–15). Rats treated with T0070907 developed key features of preeclampsia, including elevated mean arterial blood pressure, proteinuria, endothelial dysfunction, reduced pup weight, and increased platelet aggregation. T0070907-treated rats had reduced plasma vascular endothelial growth factor and increased plasma soluble fms-like tyrosine kinase 1. Furthermore, increases in total placental soluble fms-like tyrosine kinase 1 mRNA and fms-like tyrosine kinase 1 protein were also demonstrated, suggesting the placenta as the main contributor to the increased circulating levels of soluble fms-like tyrosine kinase 1. The labyrinthine trophoblast in the placentas of T0070907-treated rats were less differentiated, had increased cellular proliferation, and were strongly immunopositive for CD-31 staining, indicating adaptive angiogenesis. The present study suggests that peroxisome proliferator-activated receptor-γ may play a pivotal role in the progression of a healthy pregnancy and may critically regulate the risk of preeclampsia. These findings have important implications regarding the underlying etiology of preeclampsia and potential therapeutic targets.

12 December 2011 in Renal Failure
Verified
Journal Article
Closed access
FAFiaz Ud Din Ahmad
Fiaz Ud Din Ahmad
MSMunavvar Abdul Sattar
Munavvar Abdul Sattar
Hassaan Anwer RathoreHassaan Anwer Rathore
Hassaan Anwer Rathore
MAMohammed Hadi Abdullah
Mohammed Hadi Abdullah
STSamual Tan
Samual Tan
EJEdward James Johns
Edward James Johns
The coexistence of hypertension and diabetes results in the rapid development of nephropathy. Hydrogen sulfide (H2S) is claimed to control the vascular and renal functions. This study tested the hypothesis that exogenous H2S lowers the blood pressure and decreases the progression of nephropathy in spontaneously hypertensive rats (SHR) that were diabetic. Eighteen SHR were divided into three groups: SHR, SHR diabetic, and SHR diabetic treated with a group of Wistar–Kyoto rats serving as normotensive nondiabetic control. Diabetes was induced with streptozotocin (STZ) in two groups and one diabetic group received sodium hydrosulfide (NaHS), a H2S donor for 5 weeks. Blood pressure was measured in conscious and anesthetized states and renal cortical blood perfusion in acute studies. Plasma and urinary H2S levels, creatinine concentrations, and electrolytes were measured on three different occasions throughout the 35-day period. Diabetic SHR had higher blood pressure, lower plasma and urinary H2S levels, and renal dysfunction as evidenced by increased plasma creatinine, creatinine clearance, and decreased urinary sodium-to-potassium ratio and renal cortical blood perfusion. NaHS reduced blood pressure, increased H2S levels in plasma and urinary excretion, and reversed the STZ-induced renal dysfunction. The findings of this study suggest that the administration of exogenous H2S lowers the blood pressure and confers protection against the progression of STZ-induced nephropathy in SHR.

1 August 2011 in Hypertension
Verified
Journal Article
Closed access
PDF file
FMFergus P. McCarthy
Fergus P. McCarthy
SDSascha Drewlo
Sascha Drewlo
JKJohn Kingdom
John Kingdom
EJEdward J. Johns
Edward J. Johns
SWSarah K Walsh
Sarah K Walsh
LKLouise C. Kenny
Louise C. Kenny
Preeclampsia is a multisystemic disorder of pregnancy characterized by hypertension, proteinuria, and maternal endothelial dysfunction. It is a major cause of maternal and perinatal morbidity and mortality and is thought to be attributable, in part, to inadequate trophoblast invasion. Peroxisome proliferator-activated receptor-γ (PPAR-γ) is a ligand-activated transcription factor expressed in trophoblasts, and the vasculature of which activation has been shown to improve endothelium-dependent vasodilatation in hypertensive conditions. We investigated the effects of the administration of a PPAR-γ agonist using the reduced uterine perfusion pressure (RUPP) rat model of preeclampsia. The selective PPAR-γ agonist, rosiglitazone, was administered to pregnant rats that had undergone RUPP surgery. To investigate whether any observed beneficial effects of PPAR-γ activation were mediated by the antioxidant enzyme, heme oxygenase 1, rosiglitazone was administered in combination with the heme oxygenase 1 inhibitor tin-protoporphyrin IX. RUPP rats were characterized by hypertension, endothelial dysfunction, and elevated microalbumin:creatinine ratios. Rosiglitazone administration ameliorated hypertension, improved vascular function, and reduced the elevated microalbumin:creatinine ratio in RUPP rats. With the exception of microalbumin:creatinine ratio, these beneficial effects were abrogated in the presence of the heme oxygenase 1 inhibitor. Administration of a PPAR-γ agonist prevented the development of several of the pathophysiological characteristics associated with the RUPP model of preeclampsia, via a heme oxygenase 1–dependent pathway. The findings from this study provide further insight into the underlying etiology of preeclampsia and a potential therapeutic target for the treatment of preeclampsia.

1 February 2013 in Industrial Crops and Products
Verified
Journal Article
Closed access
AHAbdullah I. Hussain
Abdullah I. Hussain
Hassaan Anwer RathoreHassaan Anwer Rathore
Hassaan Anwer Rathore
MSMunavvar Z.A. Sattar
Munavvar Z.A. Sattar
Shahzad Ali Shahid ChathaShahzad Ali Shahid Chatha
Shahzad Ali Shahid Chatha
FAFiaz Ud Din Ahmad
Fiaz Ud Din Ahmad
EJEdward J. Johns
Edward J. Johns